Integration of Mediastinal Staging Techniques for Lung Cancer

Seminars in Thoracic and Cardiovascular Surgery

Volumn 19, Issue 3, 2007, Pages 217-224

  Detterbeck, Frank C ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

lung cancer; mediastinal staging; mediastinoscopy; non small cell lung cancer; PET

Indexed keywords

ARTICLE; CANCER INFILTRATION; CANCER SIZE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; ENDOSCOPIC ECHOGRAPHY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; INTRAOPERATIVE PERIOD; LUNG CANCER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDIASTINOSCOPY; MEDIASTINUM LYMPH NODE; NEEDLE BIOPSY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TRANSBRONCHIAL BIOPSY;

DISEASE PROGRESSION; HUMANS; LUNG NEOPLASMS; MEDIASTINAL NEOPLASMS; MEDIASTINUM; NEOPLASM STAGING; PROGNOSIS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 35648940190     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2007.07.011     Document Type: Article

References (54)

1. Detterbeck FC, Jantz M, Wallace M, et al: Invasive Mediastinal Staging of Lung Cancer: An ACCP Evidence Based Clinical Practice Guideline (ed 2). Chest 2007 (in press)
2. Detterbeck F.C., Jones D.R., and Parker Jr. L.A. Intrathoracic staging. In: Detterbeck F.C., Rivera M., Socinski M., et al. (Eds). Diagnosis and Treatment of Lung Cancer: An Evidence-Based Guide for the Practicing Clinician (2001), W.B. Saunders, Philadelphia 73-93
3. Dietlein M., Weber K., Gandjour A., et al. Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer; priority for a PET-based strategy after nodal-negative CT results. Eur J Nucl Med 27 (2000) 1598-1609
4. Gould M.K., Kuschner W., Rydzak C., et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med 139 (2003) 879-892
5. Serra M., Cicera L., Rami-Porta R., et al. Routine positron tomography (PET) and selective mediastinoscopy is as good as routine mediastinoscopy to rule out N2 disease in non-small cell lung cancer (NSCLC). J Clin Oncol 24 suppl (2006) 371s
6. Cerfolio R.J., Bryant A., Ojha B., et al. Improving the inaccuracies of clinical staging of patients with NSCLC: a prospective trial. Ann Thorac Surg 80 (2005) 1207-1214
7. Watanabe Y., Hayashi Y., Shimizu J., et al. Mediastinal nodal involvement and the prognosis of non-small cell lung cancer. Chest 100 (1991) 422-428
8. Cybulsky I.J., Lanza L.A., Ryan M.B., et al. Prognostic significance of computed tomography in resected N2 lung cancer. Ann Thorac Surg 54 (1992) 533-537
9. Ichinose Y., Kato H., Koike T., et al. Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials. Lung Cancer 34 (2001) 29-36
10. Detterbeck F: What to do with surprise N2. J Thorac Oncol 2007 (in press)
11. Detterbeck F.C., DeCamp Jr. M., Kohman L., et al. Invasive staging: the guidelines. Chest 123 (2003) 167S-175S
12. Detterbeck F.C., and Socinski M.A. Induction therapy and surgery for I-IIIa, b non-small cell lung cancer. In: Detterbeck F.C., et al. (Ed). Diagnosis and Treatment of Lung Cancer: An Evidence-Based Guide for the Practicing Clinician (2001), W. B. Saunders, Philadelphia 257-266
13. Betticher D.C., Hsu Schmitz S.F., Totsch M., et al. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial. J Clin Oncol 21 (2003) 1752-1759
14. Detterbeck F.C., Falen S., Rivera M.P., et al. Seeking a home for a PET, part 2: defining the appropriate place for positron emission tomography imaging in the staging of patients with suspected lung cancer. Chest 125 (2004) 2300-2308
15. Akhurst T., Downey R., Ginsberg M., et al. An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer. Ann Thorac Surg 72 (2002) 259-266
16. De Waele M., Hendriks J., Lauwers P., et al. Nodal status at repeat mediastinoscopy determines survival in non-small cell lung cancer with mediastinal nodal involvement, treated by induction therapy. Eur J Cardio-Thorac Surg 29 (2006) 240-243
17. De Leyn P., Stroobants S., De Wever W., et al. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 non-small-cell lung cancer: a Leuven Lung Cancer Group Study. J Clin Oncol 24 (2006) 3333-3339
18. Cerfolio R.J., Bryant A., Winokur T., et al. Repeat FDG-PET after neoadjuvant therapy is a predictor of pathologic response in patients with non-small cell lung cancer. Ann Thorac Surg 78 (2004) 1903-1909 discussion 1909
19. Cerfolio R.J., Bryant A.S., and Ojha B. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study. Thorac Cardiovasc Surg 131 (2006) 1229-1235
20. Lardinois D., Schallberger A., Betticher D., et al. Postinduction video-mediastinoscopy is as accurate and safe as video-mediastinoscopy in patients without pretreatment for potentially operable non-small cell lung cancer. Ann Thorac Surg 75 (2003) 1102-1106
21. Verhagen A.F.T., Bootsma G., Tjan-Heijnen V., et al. FDG-PET in staging lung cancer: how does it change the algorithm?. Lung Cancer 44 (2004) 175-181
22. Pozo-Rodríguez F., Martín de Nicolás J.L., Sánchez-Nistal M.A., et al. Accuracy of helical computed tomography and [18F] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable non-small-cell lung cancer. J Clin Oncol 23 (2005) 8348-8356
23. Cerfolio R.J., Bryant A.S., and Eloubeidi M.A. Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study. Chest 130 (2006) 1791-1795
24. Pearson F.G., DeLarue N., Ilves R., et al. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J Thorac Cardiovasc Surg 83 (1982) 1-11
25. Vansteenkiste J.F., DeLeyn P., Deneffe G., et al. Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Ann Thorac Surg 63 (1997) 1441-1450
26. Coughlin M., Deslauriers J., Beaulieu M., et al. Role of mediastinoscopy in pretreatment staging of patients with primary lung cancer. Ann Thorac Surg 40 (1985) 556-560
27. Goldstraw P., Mannam G., Kaplan D., et al. Surgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease). J Thorac Cardiovasc Surg 107 (1994) 19-28
28. Daly B.D.T., Mueller J., Faling L., et al. N2 lung cancer: outcome in patients with false-negative computed tomographic scans of the chest. J Thorac Cardiovasc Surg 105 (1993) 904-911
29. MacManus M.P., Hicks R., Matthews J., et al. High rate of detection of unsuspected distant metastases by PET in apparent stage III non-small-cell lung cancer: Implications for radical radiation therapy. Int J Radiation Oncology Biol Phys 50 (2001) 287-293
30. Reed C., Harpole D.H., Posther K.E., et al. Results of the American College of Surgeons Oncology Group Z0050 Trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg 126 (2003) 1943-1951
31. Weder W., Schmid R.A., Bruchhaus H., et al. Detection of extrathoracic metastases by positron emission tomography in lung cancer. Ann Thorac Surg 66 (1998) 886-893
32. Viney R.C., Boyer M.J., King M.T., et al. Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer. J Clin Oncol 22 (2004) 2357-2362
33. Farrell M.A., McAdams H.P., Herndon J.E., et al. Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease. Radiology 215 (2000) 886-890
34. Silvestri G, Gould M, Margolis M, et al: Non-invasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 2007 (in press)
35. Meyers B.F., Haddad F., Siegel B., et al. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer. J Thorac Cardiovasc Surg 131 (2006) 822-829
36. Smythe W.R. Treatment of stage I non-small cell lung carcinoma. Chest 123 suppl (2003) 181S-187S
37. Lardinois D., De Leyn P., Van Schil P., et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardio-Thorac Surg 30 (2006) 787-792
38. Bollen E.C.M., van Duin C.J., Theunissen P., et al. Mediastinal lymph node dissection in resected lung cancer: morbidity and accuracy of staging. Ann Thorac Surg 55 (1993) 961-966
39. Gaer J.A.R., and Goldstraw P. Intraoperative assessment of nodal staging at thoracotomy for carcinoma of the bronchus. Eur J Cardio-Thorac Surg 4 (1990) 207-210
40. Wu Y., Huang Z.F., Wang S.Y., et al. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 36 (2002) 1-6
41. Izbicki J.R., Passlick B., Karg O., et al. Impact on radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer. Ann Thorac Surg 59 (1995) 209-214
42. Allen M.S., Darling G., Pechet T., et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 Trial. Ann Thorac Surg 81 (2006) 1013-1020
43. Keller S.M., Adak S., Wagner H., et al. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer; from the Eastern Cooperative Oncology Group. Ann Thorac Surg 70 (2000) 358-365
44. Sugi K., Nawata K., Fujita N., et al. Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in diameter. World J Surg 22 (1998) 290-294
45. Izbicki J.R., Thetter O., Habekost M., et al. Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer: a randomized controlled trial. Br J Surg 81 (1994) 229-235
46. Funatsu T., Matsubara Y., Ikeda S., et al. Preoperative mediastinoscopic assessment of N factors and the need for mediastinal lymph node dissection in T1 lung cancer. J Thorac Cardiovasc Surg 108 (1994) 321-328
47. Martini N., Flehinger B.J., Zaman M.B., et al. Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases. Ann Surg 198 (1983) 386-397
48. Mountain C.F. Surgery for Stage IIIa-N2 non-small cell lung cancer. Cancer 73 (1994) 2589-2598
49. Andre F., Grunenwald D., Pignon J.P., et al. Survival of patients with resected N2 non-small-cell lung cancer: Evidence for a subclassification and implications. J Clin Oncol 18 (2000) 2981-2989
50. Vansteenkiste J.F., De Leyn P., Deneffe G., et al. Clinical prognostic factors in surgically treated stage IIIA-N2 non-small cell lung cancer: analysis of the literature. Lung Cancer 19 (1998) 3-13
51. Detterbeck F.C., and Jones D.R. Surgical treatment of stage IIIa (N2) non-small cell lung cancer. In: Detterbeck F.C., Rivera M., Socinski M., et al. (Eds). Diagnosis and Treatment of Lung Cancer: An Evidence-Based Guide for the Practicing Clinician (2001), W.B. Saunders, Philadelphia 244-256
52. Patterson G.A., Piazza D., Pearson F.G., et al. Significance of metastatic disease in subaortic lymph nodes. Ann Thorac Surg 43 (1987) 155-159
53. Sakao Y., Miyamoto H., Yamazaki A., et al. The spread of metastatic lymph nodes to the mediastinum from left upper lobe cancer: results of superior mediastinal nodal dissection through a median sternotomy. Eur J Cardiothorac Surg 30 (2006) 543-547
54. Okada M., Tsubota N., Yoshimura M., et al. Prognosis of completely resected pN2 non-small cell lung carcinomas: what is the significant node that affects survival?. J Thorac Cardiovasc Surg 118 (1999) 270-275